Presentation is loading. Please wait.

Presentation is loading. Please wait.

A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation 

Published byἈγλαΐη Κανακάρης-Ρούφος Modified over 5 years ago

Similar presentations

Presentation on theme: "A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation "— Presentation transcript:

1 A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation  Rahana Harjee, Jeffrey Roberts  Fertility and Sterility  Volume 111, Issue 4, Pages e51-e52 (April 2019) DOI: /j.fertnstert Copyright © Terms and Conditions

2 Figure 1 Mean peak estradiol levels by letrozole dose
Fertility and Sterility  , e51-e52DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

Download ppt "A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation "

Similar presentations

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment  Javier Domingo, M.D., Vicente.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment  Javier Domingo, M.D., Vicente.
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,

Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.

Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.
Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc. 

Edward G. Hughes, M.B., F.R.C.S.(C.), Deirdre DeJean, M.Sc. 
Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study  Arianna D'Angelo, M.D., Rachel.

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study  Arianna D'Angelo, M.D., Rachel.
Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase  Michael von Wolff, M.D., Christian J. Thaler,
Michael M. Alper, M.D.  Fertility and Sterility 

Michael M. Alper, M.D.  Fertility and Sterility 
Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?  Kutluk.

Four spontaneous pregnancies and three live births following subcutaneous transplantation of frozen banked ovarian tissue: What is the explanation?  Kutluk.
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph

Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph
Ovarian stimulation and risk of breast cancer in Swedish women

Ovarian stimulation and risk of breast cancer in Swedish women
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Albert Asante, M. D. , M. P. H. , Kenan Omurtag, M. D

Albert Asante, M. D. , M. P. H. , Kenan Omurtag, M. D
Medical treatment of ectopic pregnancy: a committee opinion

Medical treatment of ectopic pregnancy: a committee opinion
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.

Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

Similar presentations

Ads by Google